KEY FEATURES
| Full Name | Aquaporin 9 |
|---|---|
| Synonym | SSC1; Aquaglyceroporin-9; Small solute channel 1 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 15.6-1000pg/mL |
| Sensitivity | 6.4pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human AQP9 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human AQP9. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human AQP9 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human AQP9, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human AQP9. You can calculate the concentration of Human AQP9 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human AQP9 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 49.97 | 158.53 | 391.81 | 52.43 | 159.38 | 395.49 |
| Standard deviation | 3.37 | 6.34 | 19.16 | 2.86 | 8.21 | 16.57 |
| CV(%) | 6.75 | 4 | 4.89 | 5.46 | 5.15 | 4.19 |
RECOVERY
The recovery of Human AQP9 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 94-108 | 99 |
| EDTA plasma (n=8) | 91-104 | 97 |
| Cell culture media (n=8) | 92-107 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human AQP9 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with AQP9 ELISA Kits
| CFTR ELISA Kit | publications with AQP9 and CFTR |
| S100A9 ELISA Kit | publications with AQP9 and S100A9 |
| MNDA ELISA Kit | publications with AQP9 and MNDA |
Pathways associated with AQP9 ELISA Kit
| Aquaporin-mediated Transport Pathway | Aquaporin-mediated Transport Pathway |
| Bile Secretion Pathway | Bile Secretion Pathway |
| Passive Transport By Aquaporins Pathway | Passive Transport By Aquaporins Pathway |
| Transmembrane Transport Of Small Molecules Pathway | Transmembrane Transport Of Small Molecules Pathway |
| Transport Of Glycerol From Adipocytes To The Liver By Aquaporins Pathway | Transport Of Glycerol From Adipocytes To The Liver By Aquaporins Pathway |
Diseases associated with AQP9 ELISA Kit
| Brain Diseases | publications with AQP9 and Brain Diseases |
| Nervous System Diseases | publications with AQP9 and Nervous System Diseases |
| Disease Models, Animal | publications with AQP9 and Disease Models, Animal |
| Cardiovascular Diseases | publications with AQP9 and Cardiovascular Diseases |
| Fatty Liver | publications with AQP9 and Fatty Liver |
| Liver Diseases | publications with AQP9 and Liver Diseases |
| Leukemia | publications with AQP9 and Leukemia |
| Leukemia, Promyelocytic, Acute | publications with AQP9 and Leukemia, Promyelocytic, Acute |
| Inflammation | publications with AQP9 and Inflammation |
| Leukemia, Myeloid, Acute | publications with AQP9 and Leukemia, Myeloid, Acute |
Organs/Tissues associated with AQP9 ELISA Kit
| Liver | publications with AQP9 and Liver |
| Blood | publications with AQP9 and Blood |
| Brain | publications with AQP9 and Brain |
| Kidney | publications with AQP9 and Kidney |
| Vascular | publications with AQP9 and Vascular |
| Adipose Tissue | publications with AQP9 and Adipose Tissue |
| Lung | publications with AQP9 and Lung |
| Connective Tissue | publications with AQP9 and Connective Tissue |
| Intestine | publications with AQP9 and Intestine |
| Bone | publications with AQP9 and Bone |